Detalles de la búsqueda
1.
Gut mycobiome as a potential non-invasive tool in early detection of lung adenocarcinoma: a cross-sectional study.
BMC Med
; 21(1): 409, 2023 10 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37904139
2.
Prediction model for hyperprogressive disease in patients with advanced solid tumors received immune-checkpoint inhibitors: a pan-cancer study.
Cancer Cell Int
; 23(1): 224, 2023 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37777758
3.
Factors for incidence risk and prognosis of synchronous brain metastases in pulmonary large cell carcinoma patients: a population-based study.
BMC Pulm Med
; 23(1): 12, 2023 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36635639
4.
Combined effect of tetracycline and copper ion on catalase activity of microorganisms during the biological phosphorus removal.
J Environ Manage
; 304: 114218, 2022 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34891056
5.
Efficacy and safety of anti-PD-1-based therapy in combination with PARP inhibitors for patients with advanced solid tumors in a real-world setting.
Cancer Immunol Immunother
; 70(10): 2971-2980, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33740125
6.
RING finger protein 38 induces the drug resistance of cisplatin in non-small-cell lung cancer.
Cell Biol Int
; 45(2): 287-294, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32706501
7.
Immunotherapy for advanced non-small cell lung cancer with negative programmed death-ligand 1 expression: a literature review.
Transl Lung Cancer Res
; 13(2): 398-422, 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38496691
8.
Demethylation of miR-9-3 and miR-193a genes suppresses proliferation and promotes apoptosis in non-small cell lung cancer cell lines.
Cell Physiol Biochem
; 32(6): 1707-19, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24356455
9.
Deciphering pathogenic cellular module at single-cell resolution in checkpoint inhibitor-related pneumonitis.
Oncogene
; 42(42): 3098-3112, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37653115
10.
Efficacy and safety of pembrolizumab versus sintilimab treatment in patients with advanced squamous lung cancer: A real-world study in China.
Front Oncol
; 13: 1147903, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37124534
11.
Efficacy and safety of anti-PD-1 monotherapy versus anti-PD-1 antibodies plus lenvatinib in patients with advanced hepatocellular carcinoma: a real-world experience.
Ther Adv Med Oncol
; 15: 17588359231206274, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37885459
12.
Outcome of immune checkpoint inhibitors in patients with extensive-stage small-cell lung cancer and brain metastases.
Front Oncol
; 13: 1110949, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37213269
13.
[Clinical characteristics and prognostic factors of malignancy-associated hypercalcemia in squamous cell carcinoma].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 34(6): 585-9, 2012 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-23286403
14.
Rate and risk factors of recurrent immune checkpoint inhibitor-related pneumonitis in patients with lung cancer.
Transl Lung Cancer Res
; 11(3): 381-392, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35399572
15.
Rechallenge of immunotherapy beyond progression in patients with extensive-stage small-cell lung cancer.
Front Pharmacol
; 13: 967559, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36147357
16.
Efficacy and safety of crizotinib plus bevacizumab in ALK/ROS-1/c-MET positive non-small cell lung cancer: an open-label, single-arm, prospective observational study.
Am J Transl Res
; 13(3): 1526-1534, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33841676
17.
Anti-PD-1/L1 plus anti-angiogenesis therapy as second-line or later treatment in advanced lung adenocarcinoma.
J Cancer Res Clin Oncol
; 147(3): 881-891, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32909095
18.
Association of the pretreatment lung immune prognostic index with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors.
Clin Res Hepatol Gastroenterol
; 45(5): 101748, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34182184
19.
Systemic Immune-Inflammation Index and Changes of Neutrophil-Lymphocyte Ratio as Prognostic Biomarkers for Patients With Pancreatic Cancer Treated With Immune Checkpoint Blockade.
Front Oncol
; 11: 585271, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33718140
20.
Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis.
Front Oncol
; 11: 562315, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33937012